logo
Select company
Select metric
$ -383KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
58
Sector
84
Industry
95
History
60
$ 3.33Close
$ 1.26 - $ 4.19 52-Week Range
Ticker Information

Ticker

MGX

Company Name

METAGENOMI INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

METAGENOMI INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ -383K
3/31/2025$ -2.52M
12/31/2024$ 84.01M
9/30/2024$ 82.68M
12/31/2023$ -3.28M
12/31/2022$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • METAGENOMI INC's latest trailing twelve months (TTM) CF - Equity stands at $ 0.
  • Over the past 5 years, METAGENOMI INC's average CF - Equity has been $ 26.75M.
  • The median CF - Equity for METAGENOMI INC during this period was $ -191.5K
  • METAGENOMI INC reached its highest CF - Equity over the past 5 years at $ 84.01M.
  • The lowest CF - Equity recorded by METAGENOMI INC in the same timeframe $ -3.28M

METAGENOMI INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
ICCC : IMMUCELL CORP $ 4.38MWHWK : WHITEHAWK THERAPEUTICS INC $ 94.48MMRSN : MERSANA THERAPEUTICS INC $ 257KIRD : OPUS GENETICS INC $ 22.07MVRCA : VERRICA PHARMACEUTICALS INC $ 39.64MHYFT : MINDWALK HOLDINGS CORP $ 8.47MEQ : EQUILLIUM INC $ 148KBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ 1.3MDOMH : DOMINARI HOLDINGS INC $ 15.86MIVVD : INVIVYD INC $ 518K

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

MGX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -3.28M

Minimum

Dec 31, 2023

$ 84.01M

Maximum

Dec 31, 2024

$ 26.75M

Average

$ -191.5K

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 130.54K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 130.54K
median$ 0
std$ 17.65M